In Mettl3fl/fl mice and Prrx1-CreERT2;Mettl3fl/fl mice, the symptomatic AML development was detected at 24–25 days and 21–23 days after transplantation, respectively. Here, PRRX1 is linked to acute myeloid leukemia.